Decision

Eli Lilly Canada Inc. v. Novopharm Limited, 2010 FCA 219 (Olanzapine*)

Justice Nadon; Justice Sharlow; Justice Layden-Stevenson - 2010-09-07

Read full decision. Automatically generated summary:

The respondent Novopharm Limited has moved for reconsideration of the judgment of this Court dated July 21, 2010 allowing the appeal of the appellants (collectively “Lilly”) from a judgment of the Federal Court (2009 FC 1018). Lilly opposes the motion.

Decision relates to:

 

Canadian Intellectual Property